Summary
Case (C) describes the French experience with RU486 and the possibilities of making the product available worldwide and emphasises the problems that would arise should it be marketed in the United States, where abortion is a politically sensitive issue, and in the Third World, where the lack of medical facilities would pose a serious risk of the product being misused.
